Loading clinical trials...

Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT) - Study 2 | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT02436304

Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT) - Study 2

The purpose of this study is to evaluate EXE844 plus tympanostomy tubes compared to tympanostomy tubes only based on sustained clinical cure at end-of-therapy (EOT).

Lead sponsor: Alcon Research•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

WITHDRAWNPhase 4

Otiprio Versus Ciprodex Tympanostomy Tube Outcomes

NCT03347461 · Otorrhea, Otitis Media With Effusion in Children

COMPLETEDPhase 1

Pediatric Pharmacokinetic (PK) Study of EXE844 Otic Suspension in Otitis Media at the Time of Tympanostomy Tube Insertion (OMTT)

NCT02539654 · Otitis Media With Effusion in Children, Otitis Media Recurrent

COMPLETEDPhase 3

Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT)

NCT02432105 · Otitis Media With Effusion in Children, Otitis Media Recurrent

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 2, 2018Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment404

Start dateJun 2015

Last updatedJul 2, 2018

Condition

Otitis Media With Effusion in Children Otitis Media Recurrent

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 2, 2018Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions